Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.
Maxwell JA, Johnson SP, McLendon RE, Lister DW, Horne KS, Rasheed A, Quinn JA, Ali-Osman F, Friedman AH, Modrich PL, Bigner DD, Friedman HS.
Maxwell JA, et al. Among authors: friedman hs, friedman ah.
Clin Cancer Res. 2008 Aug 1;14(15):4859-68. doi: 10.1158/1078-0432.CCR-07-4807.
Clin Cancer Res. 2008.
PMID: 18676759
Free PMC article.